Drug Type Interferons |
Synonyms Interferon alpha-2b (Lee's Pharmaceutical), Recombinant Human Interferon α2b Gel, Yallaferon + [6] |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2001), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Uterine Cervicitis | CN | 07 Sep 2005 | |
Condylomata Acuminata | CN | 01 Jan 2001 | |
Herpes Genitalis | CN | 01 Jan 2001 | |
Herpes Labialis | CN | 01 Jan 2001 | |
Herpes Zoster | CN | 01 Jan 2001 | |
Uterine Diseases | CN | 01 Jan 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HPV16 Infection | Phase 3 | CN | 01 Sep 2015 | |
Gynecological infection | Phase 3 | - | 01 Mar 2011 | |
Human Papillomavirus Infection | Phase 3 | - | 01 Mar 2011 |